Aevolve AG, a new firm using the blockchain investment platform to support ‘life-saving innovative’ medical research, has released a new securitised financial product targeted investors and patients.
The new structured product - Avex.ai - is registered tracker certificate with a Swiss issued ISIN (CH0444363490) tracking the Avex token - a crypto asset that is used to purchase unique health tech products in Biospheres, a tokenised marketplace for health innovation offerings. The Avex token is also one of the first digital assets to launch through a structured product. The Biospheres platform will oversee the screening, matching, transactions and fulfilment among participants. This structur
Continue reading with a subscription to the SRP market intelligence platform.
Request DemoAlready a subscriber? Login